CTCBIO to inject 64.5 billion won into vaccine projects

Published: 2012-08-14 06:57:00

Updated: 2012-08-14 06:57:00

CTC Bio, a local biopharmaceutical company, said Friday it will inject 64.5 billion won, 14.38 percent of its stake, by December 30, 2013 into projects at expanding its manufacturing facilities for vaccines, injectables, animal drugs and feed additives.

The plans were announced at its board of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK